Seres Therapeutics
MCRB
#10776
Rank
โ‚ฌ18.14 M
Marketcap
1,81ย โ‚ฌ
Share price
-3.35%
Change (1 day)
-87.77%
Change (1 year)

EPS for Seres Therapeutics (MCRB)

EPS in 2026 (TTM): -2,51ย โ‚ฌ

According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is -2,63ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 0,57ย โ‚ฌ an increase over its 2024 EPS that were of N/A.

EPS history for Seres Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,51ย โ‚ฌ-538.67%
20250,57ย โ‚ฌ
2024N/A-100%
2023-15,89ย โ‚ฌ-61.54%
2022-41,31ย โ‚ฌ220.83%
2021-12,88ย โ‚ฌ-35.71%
2020-20,03ย โ‚ฌ-9.68%
2019-22,17ย โ‚ฌ-48.97%
2018-43,45ย โ‚ฌ9.95%
2017-39,52ย โ‚ฌ-3.91%
2016-41,13ย โ‚ฌ-1.29%
2015-41,67ย โ‚ฌ285.48%
2014-10,81ย โ‚ฌ157.99%
2013-4,19ย โ‚ฌ42.44%
2012-2,94ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
-1,94ย โ‚ฌ-26.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
-6,34ย โ‚ฌ 141.16%๐Ÿ‡บ๐Ÿ‡ธ USA